Manoel Galvao Neto

Apremilast Benefits and Risks in PsA Dr. Akhil Sood discusses abstracts 1466, 2583, 0598 and 2640 discussing the use of apremilast in PsA, presented at #ACR24. https://buff.ly/491Nc4b

6

Invited Lecture by Dr. Yong Du; Associate Professor of Radiology, Johns Hopkins Medicine: "SPECT Imaging for Alpha Radiopharmaceutical Therapy" https://lnkd.in/efqEf42Z Chapter Breakdown: 0:00 Introduction 1:15 #Radiopharmaceutical Therapy (#RPT) 3:40 Beta and alpha RPTs 7:28 Rationale for #dosimetry in RPT 9:30 RPT treatment planning flowchart 14:15 Quantitative SPECT activity estimation 15:03 SPECT vs. PET 20:00 Challenges with #SPECT imaging of alpha-emitters 26:42 Solutions for imaging alpha emitters 34:30 Animal studies of Ac-225 35:23 Patient SPECT/CT imaging (Fr-221 and Bi-213) 36:02 New alpha SPECT systems 46:47 Conclusions

100

3 Comments

Full read JAMA ILD Review article. ILD= 33% idiopathic (IPF) + 15% hypersensitivity pneumonitis + 25% from CTD. 30% of ILD has cough Chest CT 91% sensitive, 71% specific 5% decr in FVC/12 mos assoc w/ 2-fold incr in mortality Rx options nintedanib or pirfenidone, TCZ, MMF, RTX https://buff.ly/424GQ2D

88

This ppt is a great talk Importance of Vein Stents in the Iliac Vein Vein stents play a crucial role in managing iliac vein obstructions, including conditions like May-Thurner Syndrome or post-thrombotic syndrome. They help restore normal blood flow by relieving stenosis, improving symptoms such as swelling, pain, and venous ulcers. Advances in stent technology—such as flexibility, radial strength, and longer patency—have made stenting a cornerstone in treating chronic venous insufficiency. Their use is especially impactful in reducing complications and improving the quality of life for patients with severe venous outflow obstruction. Exciting Call for Miami IVC Meeting 2025 “Get ready for the future of venous care! Join us at the Miami IVC Meeting 2025, the premier gathering of vascular experts and innovators. Dive into groundbreaking research, cutting-edge technology, and hands-on workshops designed to transform patient outcomes. Whether you’re a seasoned practitioner or new to the field, this is your chance to network, learn, and shape the next era of venous intervention. Mark your calendars for an unforgettable journey into the heart of vascular excellence!”

2

Simplify Your Scheduling Workflow With SurgiCalendar

5

SCAI 2024 Scientific Sessions to focus on TAVR, PAD and other key trends in interventional cardiology

2

Great meeting today and more work planned over the coming weeks to bring some interesting research insights as to what makes PNS effective and how we can design future systems that are consistently effective for our patients in order to drive greater payor coverage and improve patient access. Looking forward to crafting a really interesting presentation for this interactive presentation at NANS and cuing up Dr. Evan Peskin to share data on functional outcomes with PNS #innovation #PNS #neuromodulation #research #patientoutcomes #understandhowitworks #NANS

28

2 Comments

Febuxostat is assoc w/ a reduced risk of kidney events and slower decline in eGFR. Metanalysis of 16 RCTs, shows febuxostat w/a reduced risk of kidney events (RR=0.56) & slower decline in eGFR; & reduced urine albumin to creatinine ratio https://buff.ly/467SXMc

22

PICC, Repeat x-ray, Echo, Foreign body

2

1 Comment

Overview of Uveitis management of adult & pediatric rheumatology. - Uveitis accounts for 10% of visual impairment globally - TNF inhib are effective; w/ IL-6 inhib as 2nd line options

7

1 Comment

Reposting a must-watch discussion on #AI's role in transforming cardiology! Join Dr. Tom C. Nguyen and myself in a compelling discussion on its impact on minimally invasive surgery and structural heart treatments. #Cardiology #Innovation

44

Highlighting a success story. Establishing a structured Radiation Oncology Residency program in a challenging post-war environment. I personally know the many wonderful radiation oncologists who were the first to graduate and become board certified and now serving their community and country. #SuccessStories #EducationandTrainig #Capacitybuilding #RadiationOncology Layth Mula-Hussain, MB ChB, MSc, EF, FRCP Edin.

26

8 Comments

Here we go. Pitching novel approaches for confirming the utility of our novel anti-viral (anti-Ebola) compounds! (Love novelty…)

3

1 Comment

Patients in the ERPM + RPT group had similar outcomes, lower costs, and saved time compared to patients in the ERPM + OPT group after SDD TKA. Further analysis is needed to determine predictive indicators for crossovers. https://lnkd.in/gcQD-_gM

5

Metanalysis of 16 RCTs shows febuxostat reduces the risk of kidney events (RR = 0.56, 95% CI 0.37-0.84, p = 0.006) and a slower decline in eGFR (vs controls) https://buff.ly/3X99qgC

10

🎯Super Short Review Series: Article #2 Managing Acute Decompensated Valvular Disease💔in the ICU 🏥 ➡️➡️➡️ Managing acute decompensated valvular disease in the ICU is complex. This article offers key insights, practical strategies, and highlights critical research gaps to improve care for critically ill patients. 💡 Key Insights from the Article: • Team-Based Care 🤝: Multidisciplinary Heart Teams are essential to optimize outcomes in these critically ill patients. • Bridging Therapies 🚑: like Balloon Aortic Valvuloplasty (BAV) and ECMO (with the LAVA technique) provide life-saving stabilization for unstable patients. • Advanced Hemodynamic Tools 🔍: Pulmonary artery catheters (PACs) are regaining importance in guiding treatment decisions. • Simple but Effective Interventions ✅: Positive Pressure Ventilation (PPV) not only supports breathing but also improves valve function. • Urgent Need for Inclusive Research 📚: ICU patients are underrepresented in clinical trials for tools like TAVR and TEER, leaving significant gaps in evidence. 📊 Key Figures and Takeaways: 1️⃣ Central Illustration – Overview of Valvular Disease Management Summarizes challenges and strategies for critically ill patients with valvular dysfunction, emphasizing tailored interventions and teamwork. 2️⃣ Figure 1 – Factors Influencing Surgical Decisions Outlines key considerations like frailty, comorbidities, and ventricular function that guide surgery, TAVR, or bridging therapies. 3️⃣ Figure 2 – Aortic Stenosis and Regurgitation Highlights diagnostic complexities and the role of Balloon Aortic Valvuloplasty (BAV) for high-risk patients. 🫀 🔑 Advanced imaging (TEE, CT) aids emergency decisions. 4️⃣ Figure 3 – Mechanical Circulatory Support (MCS) Focuses on ECMO and Impella for severe valvular failure. 🔑 LAVA technique with ECMO improves outcomes. 5️⃣ Figure 4 – Mitral Stenosis and Regurgitation Explains mitral valve dysfunction changes with TEER and PPV interventions. ⏱ 🔑 Timing of intervention is key. 6️⃣ Figure 6 – Impact of Positive Pressure Ventilation (PPV) Shows how PPV improves hemodynamics and mitral valve function in ICU. 7️⃣ Table 1 – Research Gaps Highlights the need for more clinical trial data for ICU patients on TAVR and TEER. 📥 Key figures and explanations will be shared in the comments—don’t miss them! 🙌 Special thanks to the authors for this incredible contribution to cardiology. 📖 Read the full article here: https://lnkd.in/enYPGpN5 🌎#FeelAliveNotJustSurvive 💡#Cardiology #ValvularDisease #ICU #CriticalCare #MedicalInnovation #TAVR #TEER #ECMO #HeartTeam #MedicalResearch #BAV

47

15 Comments

JAMA FULL READ review and overview of Axial Spondyloarthritis by Drs. Deodhar & Bittar - Dx often delayed 6-8 yrs - Sensitivity/Specificity of: HLA-B27 (50%/90%), CRP (35%/91%), Xray sacroiliitis (66%/68%) or MRI (78%/88%). Great tables, figs, Xrays &Reference! https://buff.ly/3DfR1a4

9